Supernus Pharmaceuticals Inc’s filing revealed that its SVP, Chief Medical Officer Rubin Jonathan unloaded Company’s shares for reported $36292.0 on Feb 21 ’25. In the deal valued at $39.15 per share,927 shares were sold. As a result of this transaction, Rubin Jonathan now holds 7,853 shares worth roughly $0.26 million.
Then, Bhatt Padmanabh P. sold 9,477 shares, generating $376,237 in total proceeds. Upon selling the shares at $39.70, the Sr. VP of IP, CSO now owns 10,149 shares.
Before that, Bhatt Padmanabh P. sold 2,573 shares. Supernus Pharmaceuticals Inc shares valued at $101,942 were divested by the Sr. VP of IP, CSO at a price of $39.62 per share. As a result of the transaction, Bhatt Padmanabh P. now holds 10,149 shares, worth roughly $0.34 million.
Cantor Fitzgerald downgraded its Supernus Pharmaceuticals Inc [SUPN] rating to a Neutral from a an Overweight in a research note published on February 19, 2025; the price target was decreased to $36 from $57. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Piper Sandler also remained covering SUPN and has decreased its forecast on September 11, 2024 with a “Neutral” recommendation from previously “an Overweight” rating.
Price Performance Review of SUPN
On Tuesday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock fall -0.03% to $33.26. Over the last five days, the stock has gained 3.20%. Supernus Pharmaceuticals Inc shares have fallen nearly -8.02% since the year began. Nevertheless, the stocks have risen 22.50% over the past one year.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-05-15, growing by 33127.0 shares to a total of 4.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 4.14 million shares. There was a rise of 0.79%, which implies that there is a positive sentiment for the stock.